Task: Answer the multiple-choice question.
Question: Which compound exhibits a 4.870% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] Cc1cc(C)c(S(=O)(=O)Nc2ncccc2C)c(C)c1
[b] CCN(CC)C(=O)CSc1nc(-c2cccs2)cc(-c2cccs2)c1C#N
[c] Cc1sc2nc(CC(=O)NN)[nH]c(=O)c2c1C
[d] COc1ccc(CCNC(=O)Nc2cccc([N+](=O)[O-])c2)cc1OC
Answer: c. Cc1sc2nc(CC(=O)NN)[nH]c(=O)c2c1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1sc2nc(CC(=O)NN)[nH]c(=O)c2c1C
Cc1sc2nc(CC(=O)NN)[nH]c(=O)c2c1C
2-(5,6-dimethyl-4-oxo-3H-thieno[2,3-d]pyrimidin-2-yl)acetohydrazide